Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

Axogen, Inc.

AXGN Clue Score44
United States Fiscal year ends December CIK 0000805928 Results filed 28 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Joseph A. Tyndall
2 Sep 2026
Director
Sold on a plan
3,500
$49.70
$173.94K
Amy McBride Wendell
11 Aug 2026
Director
Sold after exercise
13,353
$48.42
$646.59K
Marc A Began
10 Aug 2026
EVP & General Counsel
Sold after exercise
67,500
$47.35
$3.20M
Kathy Johnson Weiler
7 Aug 2026
Director
Sold on a plan
14,150
$45.30
$640.97K
Amy McBride Wendell
8 May 2026
Director
Sold after exercise
1,647
$42.60
$70.16K
Doris Quackenbush
7 May 2026
Sales VP
Sell
3,878
$43.51
$168.72K
Lindsey Marie Hartley
7 May 2026
CFO
Sold after exercise
573
$43.67
$25.02K
Lindsey Marie Hartley
7 May 2026
CFO
Sold after exercise
478
$43.67
$20.87K
Jens Kemp
7 May 2026
Chief Marketing Officer
Sell
4,000
$43.44
$173.76K
Kathy Johnson Weiler
7 May 2026
Director
Sold after exercise
16,344
$44.09
$720.62K
John Johnson
7 May 2026
Director
Sold after exercise
11,050
$43.26
$477.97K
Erick Wayne DeVinney
16 Mar 2026
Chief Innovation Officer
Sold after exercise
5,221
$32.84
$171.46K
Kathy Johnson Weiler
16 Dec 2025
Director
Sold after exercise
6,580
$29.55
$194.44K
Kathy Johnson Weiler
16 Dec 2025
Director
Sold after exercise
21,825
$29.55
$644.86K
Kathy Johnson Weiler
16 Dec 2025
Director
Sold after exercise
18,248
$29.55
$539.17K
Amy McBride Wendell
16 Dec 2025
Director
Sold after exercise
18,248
$29.31
$534.89K
Amy McBride Wendell
16 Dec 2025
Director
Sold after exercise
20,436
$29.31
$599.02K
Amy McBride Wendell
16 Dec 2025
Director
Sold after exercise
5,000
$29.31
$146.56K
Lindsey Marie Hartley
15 Dec 2025
CFO
Sold after exercise
14,812
$29.86
$442.29K
Marc A Began
11 Dec 2025
EVP & General Counsel
Sell
13,222
$30.00
$396.66K
Michael D Dale
10 Dec 2025
Chief Executive Officer
Sell
25,000
$30.00
$750.00K
John Johnson
9 Dec 2025
Director
Sold after exercise
13,141
$29.98
$393.99K
John Johnson
9 Dec 2025
Director
Sold after exercise
8,545
$29.98
$256.20K
Paul Thomas
9 Dec 2025
Director
Sell
21,399
$29.61
$633.71K
Marc A Began
9 Dec 2025
EVP & General Counsel
Sell
9,278
$31.21
$289.55K
Jens Kemp
9 Dec 2025
Chief Marketing Officer
Sell
8,156
$31.21
$254.53K
Erick Wayne DeVinney
9 Dec 2025
Chief Innovation Officer
Sell
19,517
$31.21
$609.09K
Joseph A. Tyndall
9 Dec 2025
Director
Sold after exercise
10,860
$30.98
$336.41K
Joseph A. Tyndall
9 Dec 2025
Director
Sold after exercise
14,248
$30.98
$441.36K
Michael D Dale
9 Dec 2025
Chief Executive Officer
Sell
61,463
$31.21
$1.92M
Lindsey Marie Hartley
8 Dec 2025
CFO
Sold after exercise
2,854
$31.56
$90.07K
Lindsey Marie Hartley
8 Dec 2025
CFO
Sold after exercise
11,533
$31.56
$363.94K
John Johnson
8 Dec 2025
Director
Sold after exercise
11,891
$31.22
$371.27K
John Johnson
8 Dec 2025
Director
Sold after exercise
11,802
$31.26
$368.93K
William P. Mr. Burke
11 Nov 2025
Director
Sold after exercise
3,591
$24.02
$86.25K
William P. Mr. Burke
10 Nov 2025
Director
Sold after exercise
19,227
$24.01
$461.64K
William P. Mr. Burke
6 Nov 2025
Director
Sold after exercise
5,347
$24.01
$128.37K
William P. Mr. Burke
5 Nov 2025
Director
Sold after exercise
11,431
$24.05
$274.89K
William P. Mr. Burke
30 Oct 2025
Director
Sold after exercise
18,248
$23.00
$419.70K
William P. Mr. Burke
29 Oct 2025
Director
Sold after exercise
19,799
$22.00
$435.58K
William P. Mr. Burke
29 Oct 2025
Director
Sold after exercise
20,436
$19.15
$391.44K
William P. Mr. Burke
22 Oct 2025
Director
Sold on a plan
1,457
$18.02
$26.25K
William P. Mr. Burke
6 Oct 2025
Director
Sell
736
$18.00
$13.25K
William P. Mr. Burke
3 Oct 2025
Director
Sold on a plan
14,571
$18.21
$265.28K
William P. Mr. Burke
3 Oct 2025
Director
Sold on a plan indirect
7,600
$18.21
$138.37K
William P. Mr. Burke
2 Oct 2025
Director
Sold on a plan
7,620
$18.01
$137.20K
William P. Mr. Burke
2 Oct 2025
Director
Sold on a plan indirect
2,400
$18.01
$43.22K
Erick Wayne DeVinney
16 Sep 2025
Chief Innovation Officer
Sell
1,137
$16.29
$18.52K
Joseph A. Tyndall
10 Jun 2025
Director
Sold after exercise
26,931
$10.72
$288.70K
John Johnson
9 Jun 2025
Director
Sell
4,073
$10.61
$43.21K
Guido J Neels
9 Jun 2025
Director
Sell
4,073
$10.61
$43.21K
William P. Mr. Burke
9 Jun 2025
Director
Sell
4,073
$10.61
$43.21K
Amy McBride Wendell
9 Jun 2025
Director
Sell
4,073
$10.61
$43.21K
Alan M Levine
9 Jun 2025
Director
Sell
4,073
$10.61
$43.21K
Kathy Johnson Weiler
9 Jun 2025
Director
Sell
4,073
$10.61
$43.21K
Joseph A. Tyndall
22 May 2025
Director
Sold after exercise
7,212
$11.20
$80.77K
Joseph A. Tyndall
22 May 2025
Director
Sold after exercise
12,850
$11.20
$143.92K
Joseph A. Tyndall
19 May 2025
Director
Sell
2,525
$11.63
$29.37K
Erick Wayne DeVinney
19 Mar 2025
Chief Innovation Officer
Sell
15,111
$17.50
$264.44K
Amy McBride Wendell
3 Mar 2025
Director
Sell
5,000
$20.02
$100.10K
Michael Patrick Donovan
21 Mar 2024
VP Operations
Sell
4,596
$7.68
$35.30K
Michael Patrick Donovan
21 Mar 2024
VP Operations
Sell
721
$7.68
$5.54K
Michael Patrick Donovan
21 Mar 2024
VP Operations
Sell
716
$7.68
$5.50K
Angelo Scopelianos
21 Mar 2024
Chief R&D Officer
Sold after exercise
610
$7.68
$4.68K
Angelo Scopelianos
21 Mar 2024
Chief R&D Officer
Sold after exercise
1,020
$7.68
$7.83K
Angelo Scopelianos
21 Mar 2024
Chief R&D Officer
Sold after exercise
5,251
$7.68
$40.33K
Erick Wayne DeVinney
21 Mar 2024
Chief Innovation Officer
Sell
3,141
$7.68
$24.12K
Erick Wayne DeVinney
21 Mar 2024
Chief Innovation Officer
Sell
721
$7.68
$5.54K
Erick Wayne DeVinney
21 Mar 2024
Chief Innovation Officer
Sell
716
$7.68
$5.50K
Karen L. Zaderej
21 Mar 2024
CEO
Sell
3,166
$7.68
$24.31K
Karen L. Zaderej
21 Mar 2024
CEO
Sell
3,086
$7.68
$23.70K
Karen L. Zaderej
21 Mar 2024
CEO
Sell
33,028
$7.68
$253.66K
Gregory Gene Freitag
7 Mar 2024
Director
Sell
25,000
$9.00
$225.00K
Michael Patrick Donovan
7 Mar 2024
VP Operations
Sell
36,310
$8.81
$319.89K
Peter J Mariani
11 Dec 2023
EVP & Chief Financial Officer
Sell
7,970
$7.50
$59.78K
Peter J Mariani
11 Dec 2023
EVP & Chief Financial Officer
Sell
3,120
$7.51
$23.43K
Peter J Mariani
11 Dec 2023
EVP & Chief Financial Officer
Sell
1,410
$7.52
$10.60K
Amy McBride Wendell
6 Sep 2023
Director
Buy
10,000
$6.22
$62.24K
William P. Mr. Burke
23 Aug 2023
Director
Buy indirect
10,000
$6.56
$65.60K
Guido J Neels
16 Aug 2023
Director
Buy
10,000
$6.11
$61.10K
Gregory Gene Freitag
1 Jun 2023
Director
Sold after exercise
29,480
$8.74
$257.66K
Gregory Gene Freitag
1 Jun 2023
Director
Sold after exercise
12,500
$8.65
$108.13K
Gregory Gene Freitag
23 May 2023
Director
Sell
4,640
$9.26
$42.97K
Gregory Gene Freitag
23 May 2023
Director
Sell
2,828
$9.17
$25.93K
Amy McBride Wendell
12 May 2023
Director
Exercised, kept
3,750
$9.22
$34.58K
Amy McBride Wendell
12 May 2023
Director
Exercised, kept
25,000
$9.22
$230.50K
Peter J Mariani
1 Feb 2023
EVP & Chief Financial Officer
Sold after exercise
14,550
$9.36
$136.19K
Peter J Mariani
31 Jan 2023
EVP & Chief Financial Officer
Sold after exercise
14,320
$9.55
$136.76K
Peter J Mariani
30 Jan 2023
EVP & Chief Financial Officer
Sold after exercise
14,111
$9.69
$136.74K
Peter J Mariani
27 Jan 2023
EVP & Chief Financial Officer
Sold after exercise
20,940
$10.16
$212.75K
Peter J Mariani
26 Jan 2023
EVP & Chief Financial Officer
Sold after exercise
20,939
$9.90
$207.30K
Peter J Mariani
25 Jan 2023
EVP & Chief Financial Officer
Sold after exercise
20,939
$10.23
$214.21K
Erick Wayne DeVinney
27 Dec 2022
VP Peripheral Nerve Science
Exercised, kept
20,000
$5.09
$101.80K
Karen L. Zaderej
15 Dec 2022
CEO
Exercised, kept
26,746
$5.09
$136.14K
Peter J Mariani
14 Dec 2022
EVP & Chief Financial Officer
Exercised, kept
19,364
$5.04
$97.59K
Peter J Mariani
16 Nov 2022
EVP & Chief Financial Officer
Sell
10,649
$11.88
$126.51K
Gregory Gene Freitag
14 Nov 2022
Director
Sell
13,000
$12.74
$165.62K
Gregory Gene Freitag
8 Nov 2022
Director
Sell
13,000
$12.50
$162.50K
Gregory Gene Freitag
10 Aug 2022
Director
Sell
8,886
$9.70
$86.16K
Gregory Gene Freitag
8 Aug 2022
Director
Sell
13,046
$10.37
$135.29K
Gregory Gene Freitag
4 Aug 2022
Director
Sell
24,000
$10.64
$255.36K
Gregory Gene Freitag
25 Jul 2022
Director
Exercised, kept
83,000
$3.38
$280.54K
Michael Patrick Donovan
22 Feb 2022
VP Operations
Exercised, kept
5,000
$5.45
$27.25K
Michael Patrick Donovan
22 Feb 2022
VP Operations
Exercised, kept
10,000
$5.09
$50.90K
Erick Wayne DeVinney
15 Dec 2021
VP Peripheral Nerve Science
Exercised, kept
10,000
$3.67
$36.70K
Karen L. Zaderej
24 Nov 2021
CEO
Exercised, kept
52,375
$8.95
$468.76K
Karen L. Zaderej
13 Aug 2021
CEO
Exercised, kept
46,500
$3.67
$170.66K
Karen L. Zaderej
12 Aug 2021
CEO
Exercised, kept
8,254
$5.09
$42.01K
Karen L. Zaderej
10 Aug 2021
CEO
Exercised, kept
75,000
$5.09
$381.75K
Karen L. Zaderej
6 Aug 2021
CEO
Sell
2,083
$19.16
$39.91K
Karen L. Zaderej
6 Aug 2021
CEO
Sell
22,902
$18.41
$421.63K
Karen L. Zaderej
6 Aug 2021
CEO
Sell
1,259
$19.18
$24.15K
Karen L. Zaderej
6 Aug 2021
CEO
Sell
14,756
$18.40
$271.51K
Michael Patrick Donovan
21 Jul 2021
VP Operations
Sell
1,935
$20.04
$38.78K
Gregory Gene Freitag
17 Jun 2021
Director
Exercised, kept
9,250
$19.17
$177.32K
Gregory Gene Freitag
4 Jun 2021
Director
Exercised, kept
24,000
$3.67
$88.08K
Maria D. Martinez
4 Jun 2021
Chief Human Resources Officer
Sell
2,652
$18.86
$50.02K
Gregory Gene Freitag
26 May 2021
Director
Exercised, kept
50,000
$8.95
$447.50K
Gregory Gene Freitag
26 May 2021
Director
Exercised, kept
15,000
$5.45
$81.75K
Gregory Gene Freitag
26 May 2021
Director
Exercised, kept
6,000
$5.45
$32.70K
Gregory Gene Freitag
26 May 2021
Director
Exercised, kept
9,000
$5.09
$45.81K
Gregory Gene Freitag
26 May 2021
Director
Exercised, kept
22,954
$3.67
$84.24K
Guido J Neels
19 May 2021
Director
Exercised, kept
15,000
$5.09
$76.35K
Guido J Neels
19 May 2021
Director
Exercised, kept
25,000
$3.80
$95.00K
Erick Wayne DeVinney
28 Apr 2021
VP of Clin. & Trans. Sciences
Exercised, kept
10,000
$2.86
$28.60K
Karen L. Zaderej
16 Apr 2021
CEO
Exercised, kept
100,000
$5.09
$509.00K
Karen L. Zaderej
25 Mar 2021
CEO
Exercised, kept
34,500
$3.67
$126.62K
Gregory Gene Freitag
25 Feb 2021
Director
Sell
24,000
$22.06
$529.44K
Michael Patrick Donovan
18 Feb 2021
VP Operations
Sell
1,808
$19.15
$34.62K
Michael Patrick Donovan
5 Feb 2021
VP Operations
Exercised, kept
20,000
$5.14
$102.80K
Karen L. Zaderej
8 Jan 2021
CEO
Sell
65,000
$20.00
$1.30M
Michael Patrick Donovan
30 Dec 2020
VP Operations
Sell
1,733
$17.48
$30.29K
Isabelle Billet
29 Dec 2020
Chief Strategy and BD Officer
Sell
649
$17.81
$11.56K
Maria D. Martinez
29 Dec 2020
Chief Human Resources Officer
Sell
567
$17.81
$10.10K
Mark Louis Friedman
29 Dec 2020
VP,Regulatory & Quality
Sell
567
$17.81
$10.10K
Karen L. Zaderej
29 Dec 2020
CEO
Sell
3,500
$17.81
$62.34K
Angelo Scopelianos
29 Dec 2020
VP Research & Development
Sell
567
$17.81
$10.10K
Peter J Mariani
29 Dec 2020
Chief Financial Officer
Sell
1,293
$17.81
$23.03K
Gregory Gene Freitag
29 Dec 2020
Director
Sell
916
$17.81
$16.31K
Michael Patrick Donovan
29 Dec 2020
VP Operations
Sell
567
$17.81
$10.10K
Erick Wayne DeVinney
29 Dec 2020
VP, Clinical&Translational Sc
Sell
371
$17.81
$6.61K
Karen L. Zaderej
23 Dec 2020
CEO
Exercised, kept
19,375
$4.81
$93.19K
Michael Patrick Donovan
22 Dec 2020
VP Operations
Sell
279
$17.19
$4.80K
Mark Louis Friedman
21 Dec 2020
VP,Regulatory & Quality
Sell
96
$16.42
$1.58K
Peter J Mariani
21 Dec 2020
Chief Financial Officer
Sell
481
$16.42
$7.90K
Michael Patrick Donovan
21 Dec 2020
VP Operations
Sell
96
$16.42
$1.58K
Gregory Gene Freitag
21 Dec 2020
Director
Sell
379
$16.42
$6.22K
Erick Wayne DeVinney
21 Dec 2020
VP, Clinical&Translational Sc
Sell
147
$16.42
$2.41K
Karen L. Zaderej
21 Dec 2020
CEO
Sell
1,275
$16.42
$20.94K
Erick Wayne DeVinney
15 Dec 2020
VP, Clinical&Translational Sc
Exercised, kept
15,000
$4.81
$72.15K
Mark Louis Friedman
3 Dec 2020
VP,Regulatory & Quality
Exercised, kept
3,187
$3.67
$11.70K
Mark Louis Friedman
3 Dec 2020
VP,Regulatory & Quality
Exercised, kept
625
$4.81
$3.01K
Karen L. Zaderej
9 Nov 2020
CEO
Sell
14,000
$14.53
$203.42K
Michael Patrick Donovan
9 Nov 2020
VP Operations
Sell
17,617
$15.00
$264.26K
Peter J Mariani
30 Oct 2020
Chief Financial Officer
Sold after exercise
1,745
$12.41
$21.66K
Peter J Mariani
30 Oct 2020
Chief Financial Officer
Sold after exercise
12,854
$12.41
$159.52K
Peter J Mariani
30 Oct 2020
Chief Financial Officer
Sold after exercise
1,084
$12.41
$13.45K
Peter J Mariani
30 Oct 2020
Chief Financial Officer
Sold after exercise
60,000
$12.41
$744.72K
Gregory Gene Freitag
15 Sep 2020
Director
Exercised, kept
13,046
$3.67
$47.88K
Gregory Gene Freitag
29 May 2020
General Counsel
Exercised, kept
125,000
$3.50
$437.50K
Michael Patrick Donovan
28 May 2020
VP Operations
Exercised, kept
5,000
$5.14
$25.70K
Michael Patrick Donovan
28 May 2020
VP Operations
Exercised, kept
10,000
$3.67
$36.70K
Erick Wayne DeVinney
28 Apr 2020
VP, Clinical&Translational Sc
Exercised, kept
2,530
$0.27
$683.10
Karen L. Zaderej
16 Apr 2020
CEO
Exercised, kept
11,625
$4.81
$55.92K
Robert James Rudelius
1 Jan 2020
Director
Exercised, kept
13,000
$2.75
$35.75K
Michael Patrick Donovan
8 Oct 2019
VP Operations
Exercised, kept
1,500
$2.90
$4.35K
Michael Patrick Donovan
8 Oct 2019
VP Operations
Exercised, kept
5,000
$4.81
$24.05K
Maria D. Martinez
14 Aug 2019
Chief Human Resources Officer
Buy
2,000
$15.13
$30.26K
Isabelle Billet
13 Aug 2019
Chief Strategy and BD Officer
Buy
5
$15.08
$75.40
Isabelle Billet
13 Aug 2019
Chief Strategy and BD Officer
Buy
100
$15.08
$1.51K
Isabelle Billet
13 Aug 2019
Chief Strategy and BD Officer
Buy
100
$15.08
$1.51K
Isabelle Billet
13 Aug 2019
Chief Strategy and BD Officer
Buy
100
$15.08
$1.51K
Isabelle Billet
13 Aug 2019
Chief Strategy and BD Officer
Buy
100
$15.12
$1.51K
Isabelle Billet
13 Aug 2019
Chief Strategy and BD Officer
Buy
200
$15.11
$3.02K
Isabelle Billet
13 Aug 2019
Chief Strategy and BD Officer
Buy
100
$15.12
$1.51K
Isabelle Billet
13 Aug 2019
Chief Strategy and BD Officer
Buy
100
$15.11
$1.51K
Isabelle Billet
13 Aug 2019
Chief Strategy and BD Officer
Buy
100
$15.12
$1.51K
Isabelle Billet
13 Aug 2019
Chief Strategy and BD Officer
Buy
8
$15.12
$120.96
Isabelle Billet
13 Aug 2019
Chief Strategy and BD Officer
Buy
4
$15.12
$60.48
Isabelle Billet
13 Aug 2019
Chief Strategy and BD Officer
Buy
88
$15.12
$1.33K
Isabelle Billet
13 Aug 2019
Chief Strategy and BD Officer
Buy
4,630
$15.11
$69.96K
Quentin S. Blackford
12 Aug 2019
Director
Buy
14,170
$14.10
$199.80K
Karen L. Zaderej
9 Aug 2019
CEO
Buy
75,000
$13.50
$1.01M
Quentin S. Blackford
9 Aug 2019
Director
Buy
200
$13.07
$2.61K
Quentin S. Blackford
9 Aug 2019
Director
Buy
1,165
$13.10
$15.26K
Mark Stephen Gold
9 Aug 2019
Director
Buy indirect
100
$13.04
$1.30K
Mark Stephen Gold
9 Aug 2019
Director
Buy indirect
700
$13.05
$9.14K
Mark Stephen Gold
9 Aug 2019
Director
Buy indirect
1,000
$13.13
$13.13K
Mark Stephen Gold
9 Aug 2019
Director
Buy indirect
100
$13.04
$1.30K
Mark Stephen Gold
9 Aug 2019
Director
Buy indirect
100
$13.04
$1.30K
Mark Stephen Gold
9 Aug 2019
Director
Buy indirect
2,000
$13.11
$26.21K
Amy McBride Wendell
13 Jun 2019
Director
Buy
5,000
$20.25
$101.25K
Michael Patrick Donovan
13 Jun 2019
VP Operations
Sell
20,000
$20.00
$400.00K
Karen L. Zaderej
29 May 2019
CEO
Exercised, kept
18,056
$0.27
$4.88K
David K Hansen
13 May 2019
VP Finance & Treasurer
Sell
20,000
$22.63
$452.60K
Gregory Gene Freitag
30 Nov 2018
General Counsel
Sell
45,000
$33.00
$1.49M
Karen L. Zaderej
19 Nov 2018
CEO
Exercised, kept
70,000
$2.74
$191.80K
Karen L. Zaderej
19 Nov 2018
CEO
Exercised, kept
30,000
$2.74
$82.20K
Gregory Gene Freitag
15 Nov 2018
General Counsel
Sell
20,000
$32.25
$645.00K
Karen L. Zaderej
14 Nov 2018
CEO
Sell
12,000
$32.93
$395.16K
Karen L. Zaderej
13 Nov 2018
CEO
Sell
13,000
$33.42
$434.46K
Erick Wayne DeVinney
13 Nov 2018
VP, Clinical&Translational Sc
Exercised, kept
274
$0.27
$73.98
Erick Wayne DeVinney
13 Nov 2018
VP, Clinical&Translational Sc
Exercised, kept
35,000
$2.74
$95.90K
Jamie Mark Grooms
20 Sep 2018
Director
Exercised, kept
12,000
$2.75
$33.00K
Jamie Mark Grooms
20 Sep 2018
Director
Exercised, kept
494
$0.27
$133.38
Amy McBride Wendell
14 Aug 2018
Director
Buy
5,000
$36.89
$184.45K
Shawn F McCarrey
7 Aug 2018
SVP Sales
Exercised, kept
55,000
$3.67
$201.85K
Karen L. Zaderej
2 Aug 2018
CEO
Exercised, kept
175,000
$2.74
$479.50K
Robert James Rudelius
8 Jun 2018
Director
Exercised, kept
12,000
$2.75
$33.00K
Mark Stephen Gold
1 Jun 2018
Director
Exercised, kept
15,000
$14.85
$222.75K
Shawn F McCarrey
16 May 2018
SVP Sales
Sell
10,000
$43.47
$434.70K
Michael Patrick Donovan
26 Mar 2018
VP Operations
Exercised, kept
30,000
$2.74
$82.20K
David K Hansen
22 Mar 2018
VP Finance & Treasurer
Exercised, kept
1,500
$2.75
$4.13K
David K Hansen
22 Mar 2018
VP Finance & Treasurer
Exercised, kept
35,000
$2.74
$95.90K
Gregory Gene Freitag
21 Mar 2018
General Counsel & SVP BD
Exercised, kept
15,000
$4.81
$72.15K
Gregory Gene Freitag
21 Mar 2018
General Counsel & SVP BD
Exercised, kept
16,000
$2.46
$39.36K
Gregory Gene Freitag
1 Mar 2018
General Counsel & SVP BD
Exercised, kept
36,000
$2.74
$98.64K
Jamie Mark Grooms
21 Feb 2018
Director
Sell indirect
57,406
$28.40
$1.63M
Jamie Mark Grooms
20 Feb 2018
Director
Sell indirect
36,740
$27.90
$1.03M
Jamie Mark Grooms
16 Feb 2018
Director
Sell indirect
26,655
$27.35
$729.01K
Jamie Mark Grooms
15 Feb 2018
VP, CFO
Sell indirect
43,403
$27.11
$1.18M
Jamie Mark Grooms
14 Feb 2018
VP, CFO
Sell indirect
9,073
$26.71
$242.34K
Jamie Mark Grooms
14 Feb 2018
VP, CFO
Sell indirect
32,936
$26.72
$880.05K
Jamie Mark Grooms
13 Feb 2018
VP, CFO
Sell indirect
3,200
$26.22
$83.90K
Jamie Mark Grooms
13 Feb 2018
VP, CFO
Sell indirect
7,100
$26.20
$186.02K
Jamie Mark Grooms
12 Dec 2017
Director
Sell
16,585
$26.34
$436.85K
Jamie Mark Grooms
11 Dec 2017
Director
Sell
21,820
$26.35
$574.96K
Jamie Mark Grooms
8 Dec 2017
Director
Sell
31,805
$26.37
$838.70K
Jamie Mark Grooms
7 Dec 2017
Director
Sell
31,200
$26.50
$826.80K
Jamie Mark Grooms
6 Dec 2017
Director
Sell
21,290
$26.22
$558.22K
Guido J Neels
20 Nov 2017
Director
Sell indirect
1,150,000
$19.74
$22.70M
EW Healthcare Partners, L.P.
20 Nov 2017
10% owner
Sell
1,150,000
$19.74
$22.70M
Mark Stephen Gold
13 Nov 2017
Director
Exercised, kept
15,000
$5.09
$76.35K
Jamie Mark Grooms
1 Nov 2017
Director
Exercised, kept
14,379
$0.27
$3.88K
Mark Louis Friedman
24 Oct 2017
VP,Regulatory & Quality
Exercised, kept
16,829
$1.07
$18.01K
Mark Louis Friedman
24 Oct 2017
VP,Regulatory & Quality
Exercised, kept
4,375
$4.81
$21.04K
Mark Louis Friedman
24 Oct 2017
VP,Regulatory & Quality
Exercised, kept
5,313
$3.67
$19.50K
Mark Louis Friedman
24 Oct 2017
VP,Regulatory & Quality
Exercised, kept
1,250
$5.45
$6.81K
Mark Louis Friedman
24 Oct 2017
VP,Regulatory & Quality
Exercised, kept
40,000
$2.74
$109.60K
Gregory Gene Freitag
25 Sep 2017
General Counsel & SVP BD
Exercised, kept
10,000
$2.74
$27.40K
Robert James Rudelius
11 Sep 2017
Director
Sell
16,143
$18.00
$290.57K
Robert James Rudelius
8 Sep 2017
Director
Exercised, kept
20,000
$3.50
$70.00K
Gregory Gene Freitag
27 Aug 2017
General Counsel & SVP BD
Exercised, kept
23,000
$2.74
$63.02K
Mark Stephen Gold
30 May 2017
Director
Exercised, kept
5,000
$8.95
$44.75K
Mark Stephen Gold
22 May 2017
Director
Exercised, kept
15,000
$4.81
$72.15K
Michael Patrick Donovan
14 Mar 2017
VP Operations
Exercised, kept
5,000
$2.74
$13.70K
Michael Patrick Donovan
14 Mar 2017
VP Operations
Exercised, kept
4,659
$0.27
$1.26K
Erick Wayne DeVinney
14 Mar 2017
VP, Clinical&Translational Sc
Exercised, kept
359
$0.27
$96.93
Erick Wayne DeVinney
14 Mar 2017
VP, Clinical&Translational Sc
Exercised, kept
4,659
$0.27
$1.26K
Gregory Gene Freitag
30 Dec 2016
General Counsel & SVP BD
Exercised, kept
23,000
$2.74
$63.02K

What was left out

Form 4 filings counted 472
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 48
Sales at will 93
Transactions with no price 0
Shares from compensation/vesting 5,060,938
Sales filed before the plan box existed 57
History held since 24 Sep 2007